TGFB1 and acute myeloid leukemia: Treatment with ITD1 significantly attenuated the AML-exos-induced proliferation and migration of Thp-1 cells (Figure 5D,E), underscoring the critical contribution of exosomal TGF-β to leukemic cell behavior.